Related Experiment Video
Updated: Apr 20, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Myocerebrohepatopathy spectrum disorder due to POLG mutations: A clinicopathological report
Hesham Montassir1, Yoshihiro Maegaki2, Kei Murayama3
1Division of Child Neurology, Faculty of Medicine, Tottori University, Yonago, Japan; Department of Family Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Insights
This study details a Japanese infant with myocerebrohepatopathy spectrum disorder caused by POLG mutations. The case highlights severe multi-organ dysfunction and specific brain lesions in mitochondrial DNA depletion disorders.
Area of Science:
- Genetics
- Neurology
- Hepatology
Background:
- Mitochondrial DNA depletion disorders (MDDs) are a group of severe genetic conditions.
- Mutations in the polymerase gamma (POLG) gene are a common cause of MDDs.
- Myocerebrohepatopathy spectrum (MCHS) disorder is a severe form of MDD affecting multiple organs.
Observation:
- A Japanese infant presented with failure to thrive, vomiting, hypotonia, and hepatomegaly.
- Laboratory findings included hepatocellular dysfunction and elevated cerebrospinal fluid protein and lactate.
- The infant experienced rapid deterioration and died at 8 months of age.
Findings:
- Autopsy revealed liver fatty degeneration and fibrosis, with spongy changes and demyelination in the brain.
- Reduced mitochondrial DNA copy number and impaired respiratory chain enzyme activity were observed in the liver.
- Genetic analysis identified compound heterozygous POLG mutations (I1185T/A957V).
Implications:
- This case underscores the variable organ involvement and distinct neuropathological features in POLG-related MCHS.
- Understanding these specific patterns is crucial for diagnosing and managing mitochondrial DNA depletion disorders.
- Further research into genotype-phenotype correlations in POLG mutations is warranted.
Abstract:
We report on the clinical, neuropathological, and genetic findings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations. A girl manifested poor sucking and failure to thrive since 4 months of age and had frequent vomiting and developmental regression at 5 months of age. She showed significant hypotonia and hepatomegaly. Laboratory tests showed hepatocellular dysfunction and elevated protein and lactate levels in the cerebrospinal fluid. Her liver function and neurologic condition exacerbated, and she died at 8 months of age. At autopsy, fatty degeneration and fibrosis were observed in the liver. Neuropathological examination revealed white matter-predominant spongy changes with Alzheimer type II glia and loss of myelin. Enzyme activities of the respiratory chain complex I, III, and IV relative to citrate synthase in the muscle were normal in the biopsied muscle tissue, but they were reduced in the liver to 0%, 10%, and 14% of normal values, respectively. In the liver, the copy number of mitochondrial DNA compared to nuclear DNA was reduced to 3.3% of normal values as evaluated by quantitative polymerase chain reaction. Genetic analysis revealed compound heterozygous mutations for POLG (I1185T/A957V). This case represents the differential involvement of multiple organs and phenotype-specific distribution of brain lesions in mitochondrial DNA depletion disorders.
More Related Videos
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
Related Concept Videos
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Hepatic Encephalopathy
Animal Mitochondrial Genetics
Huntington Disease l: Introduction
Lysosomal Hydrolases